Diabetes

What Are Diabetes? 

Diabetes mellitus affects over 537 million adults globally and is the leading cause of blindness, kidney failure, and lower limb amputation in working-age adults. Effective blood glucose management through appropriate pharmacotherapy significantly reduces the risk of all major complications. AmozonPill stocks 156 generic diabetes medications across all major drug classes — biguanides, sulfonylureas, DPP-4 inhibitors, SGLT-2 inhibitors, GLP-1 agonists, thiazolidinediones, and insulins — sourced from FDA-inspected, WHO-GMP manufacturers at up to 95% below brand-name prices. 

Drug Classes Available 

• Biguanides: Metformin (500 mg, 850 mg, 1000 mg, SR) — first-line treatment for Type 2 diabetes. Reduces hepatic glucose output, improves insulin sensitivity, weight-neutral, and cardioprotective. Inexpensive and extensively evidence-based. 

• Sulfonylureas: Glipizide, Gliclazide, Glibenclamide, Glimepiride — stimulate pancreatic insulin secretion. Effective and affordable; risk of hypoglycaemia if meals are skipped. 

• DPP-4 Inhibitors (Gliptins): Sitagliptin, Vildagliptin, Saxagliptin, Teneligliptin — block DPP-4 enzyme, increasing active GLP-1. Weight-neutral, low hypoglycaemia risk. Used as second-line therapy or in combination with Metformin. 

• SGLT-2 Inhibitors: Dapagliflozin, Empagliflozin, Canagliflozin — block glucose reabsorption in the kidney, reducing blood glucose and body weight. Also protect the kidneys and heart — cardio- and renoprotective beyond glucose lowering. 

• Thiazolidinediones: Pioglitazone — improves peripheral insulin sensitivity. Used as add-on therapy; particularly useful in fatty liver disease and insulin-resistant Type 2 diabetes. 

• Insulins: Regular insulin, NPH, Insulin Glargine, Premixed 70/30 — essential for Type 1 diabetes and advanced Type 2. Available in multiple formulations and concentrations. 

 Why Buy Generic?

• Generic Metformin from $6/month vs $30+ for Glucophage brand 
• Generic Sitagliptin from $22 vs $180+ for Januvia brand 
• Generic Dapagliflozin from $28 vs $350+ for Farxiga brand 
• FDA-inspected, WHO-GMP-certified manufacturers 
• Free shipping on orders over $199 

How to Choose the Right Product 

For newly diagnosed Type 2 diabetes: Metformin 500 mg twice daily with meals is the universal first step — titrate to 1000–2000 mg/day over 4 weeks. If HbA1c remains above target after 3 months: add a DPP-4 inhibitor (Sitagliptin) or SGLT-2 inhibitor (Dapagliflozin). For patients with cardiovascular disease or CKD: an SGLT-2 inhibitor is preferred as second agent. For patients requiring insulin: Glargine once daily with Metformin is the standard basal regimen. All diabetes pharmacotherapy requires regular HbA1c, renal function, and lipid monitoring. 

Frequently Asked Questions

Is Metformin still the best first choice for Type 2 diabetes? 

Yes. Metformin remains the universal first-line agent in all major diabetes guidelines (ADA, EASD, WHO) for Type 2 diabetes. It is safe, effective, weight-neutral, cardioprotective, and the least expensive oral antidiabetic agent — generic Metformin is available from $6/month. 

What is the difference between DPP-4 inhibitors and SGLT-2 inhibitors? 

DPP-4 inhibitors (Sitagliptin) work by increasing insulin secretion after meals — they are weight-neutral with low hypoglycaemia risk. SGLT-2 inhibitors (Dapagliflozin) work by removing glucose via urine — they also reduce body weight, blood pressure, and importantly protect the kidneys and heart independent of glucose lowering. 

Can I take Metformin if I have kidney disease? 

Metformin is contraindicated in severe CKD (eGFR below 30 mL/min) due to risk of lactic acidosis. It requires dose reduction at eGFR 30–45 and is used with monitoring at eGFR 45–60. SGLT-2 inhibitors are the preferred add-on in diabetic kidney disease with preserved renal function. 

What is the risk of hypoglycaemia with diabetes medicines? 

Metformin, DPP-4 inhibitors, SGLT-2 inhibitors, and Pioglitazone have very low hypoglycaemia risk. Sulfonylureas and insulin carry significant hypoglycaemia risk, particularly when meals are missed or with exercise. Always carry glucose tablets or a sugary drink when on sulfonylureas or insulin. 

How often should HbA1c be checked? 

HbA1c (a 3-month average blood glucose measure) should be checked every 3 months when adjusting therapy, and every 6 months once blood glucose is stable and well-controlled. Target is typically below 7% (53 mmol/mol), though individual targets vary by age and risk profile. 

Is generic insulin as effective as brand-name insulin? 

Yes. Generic and biosimilar insulins approved by regulatory authorities meet the same strict standards of efficacy and safety as originator products. Regular monitoring of blood glucose when switching insulin formulations is recommended.